DrugPatentWatch Database Preview
DIATRIZOATE MEGLUMINE Drug Profile
or, see our see our flat-rate plans
When do Diatrizoate Meglumine patents expire, and when can generic versions of Diatrizoate Meglumine launch?
The generic ingredient in DIATRIZOATE MEGLUMINE is diatrizoate meglumine. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.
Summary for DIATRIZOATE MEGLUMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 12 |
| Clinical Trials: | 36 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DIATRIZOATE MEGLUMINE at DailyMed |
Pharmacology for DIATRIZOATE MEGLUMINE
| Drug Class | Radiographic Contrast Agent |
| Mechanism of Action | X-Ray Contrast Activity |
Medical Subject Heading (MeSH) Categories for DIATRIZOATE MEGLUMINE
US Patents and Regulatory Information for DIATRIZOATE MEGLUMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bracco | DIATRIZOATE MEGLUMINE | diatrizoate meglumine | INJECTABLE;INJECTION | 010040-017 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
or, see our see our flat-rate plans
